The global insulin delivery pens market size is predicted to increase from USD 25,578 million in 2025 and is anticipated to ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out ...

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

The updated device allows users to pair the sensor with Medtronic’s insulin pumps, and is expected to grow the company’s ...

Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as ...

Pallavi was arrested for murdering her husband. Pallavi alleged that her husband was giving drugs to their daughter and ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Read more about Deep reinforcement learning could redefine insulin delivery for diabetes patients on Devdiscourse ...

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...